Objective To systematically assess credibility and certainty of associations between
cannabis, cannabinoids, and cannabis based medicines and human health, from …

Background Comprehensive literature reviews of historical perspectives and evidence
supporting cannabis/cannabinoids in the treatment of pain, including migraine and …

Background Drug development is currently hampered by high attrition rates; many
developed treatments fail during clinical testing. Part of the attrition may be due to low …

Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …

Cannabidiol (CBD) is a non-intoxicating and generally well-tolerated constituent of cannabis
which exhibits potential beneficial properties in a wide range of diseases, including …

The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention,
with speculation that CBD can be useful in a wide range of conditions. Only one product, a …

Purpose of review There have been many debates, discussions, and published writings
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …

BACKGROUND. Cannabidiol (CBD) is a nonpsychoactive phytocannabinoid used in
multiple sclerosis and intractable epilepsies. Preclinical studies show CBD has numerous …

Cannabidiol (CBD) is a non-intoxicating cannabinoid derived from Cannabis sativa. CBD
initially drew scientific interest due to its anticonvulsant properties but increasing evidence of …

Aims Preclinical studies demonstrate that cannabidiol (CBD) elicits an antinociceptive
response in animal models of neuropathic pain; in humans, limited data are available to …